Skip to content

Released Jul 28, 2016, after the close

10-Q filed Jul 28, 2016, 28 days after period end · 0000917520-16-000092

Q2 2016 · 10-Q
Revenue$249.31M+17.2% vs Q2 2015+5.3% vs Q1 2016
Net Income$12.76M+155.2% vs Q2 2015−4.9% vs Q1 2016
EPS Diluted$0.16+100.0% vs Q2 2015−11.1% vs Q1 2016
Gross Profit$159,744,000+16.2%
Operating Income$22,377,000−8.1%
Operating Cash Flowderived$38,079,000+36.1%
Free Cash Flowderived$29,812,000+62.4%
Margins · derived
Gross margin64.1%−0.5 pt vs Q2 2015
Operating margin9.0%−2.5 pt vs Q2 2015
Net margin5.1%+2.8 pt vs Q2 2015

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2016Q2 2015Q2 2014Q2 2013
Revenue$249.31M$212.67M$231.35M$205.55M
Net Income$12.76M$5.00M$4.83M$1.52M
EPS Diluted$0.16$0.08$0.15$0.05

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR